PL EN


2018 | 2 | 139-143
Article title

Dextromethorphan recreational use and poisoning – the social and psychological background

Content
Title variants
Languages of publication
EN
Abstracts
References
  • Derkacz M, Wicha J, Flisek J, et al. Stosowanie leków OTC przez pacjentów Poradni Lekarza Rodzinnego. Fam Med Prim Care Rev 2014;16(3): 216–218 (in Polish)
  • Gomólka E, Hydzik P, Szkolnicka B. Zatrucia paracetamolem, salicylanami i dekstrometorfanem – ocena problemu na podstawie danych Pracowni Toksykologii oraz Ośrodka Informacji Toksykologicznej w Krakowie z lat 2010–2015. Przegl Lek 2016; 73(12): 813–817 (in Polish
  • Kabata P, Schetz D, Waldman W, et al. Analiza zatruć nowymi substancjami psychoaktywnymi (NPS) w województwie pomorskim,w okresie od stycznia do lipca 2015. Przegl Lek 2015; 72(10): 517–521 (in Polish).
  • Chyka M, Park EH , McKenzie A, et al. Signs and symptoms of Dextromethorphan exposure from YouTube. PLoS ONE 2014; 9(2): e82452.
  • Piątek A, Koziarska-Rościszewska M, Zawilska J. Recreational use of over-the-counter drugs: the doping of the brain. Alcohol Subst Addict 2015; 28: 65–77.
  • Reissig CJ, Carter LP, Johnson MW, et al. High doses of dextromethorphan, an NMDA antagonist, produce effects similar to classic hallucinogens.Psychopharmacology (Berl) 2012; 221(1): 1–15.
  • Shafi F, Imran M, Usman HF et al. Deaths due to abuse of dextromethorphan sold over-the – counter in Pakistan. Egypt J Forensic Sci 2016; 6: 280–283.
  • Zając M, Andrzejczyk A, Kuich A, et al. Rekreacyjne stosowanie dekstrometorfanu – ocena na podstawie doświadczeń internautów.Przegl Lek 2013; 70(8): 525–527 (in Polish).
  • World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines.Geneva: WHO ; 1992.
  • Anderson IB . Dextromethorphan. In: Olson KR, ed. Poisoning and drug overdose. Sixth edition. New York: The McGraw-Hill Company;Geneva: WHO ; 1992.
  • Miller SC . Dextromethorphan psychosis, dependence and psychical withdrawal. Addict Biol 2005; 10(4): 325–327.
  • Soyka M, Bondy B, Eisenburg B, et al. NMDA receptor challenge with dextromethorphan — subjective response, neuroendocrinological findings and possible clinical implications. J Neural Transm 2000; 107: 701–714.
  • Ziaee V, Akbari Hamed E, Hoshmand A, et al. Side effects of dextromethorphan abuse, a case series. Addict Behav 2005; 30(8): 1607––1613.
  • Murray S, Brewerton T. Abuse of over-the-counter dextromethorphan by teenagers. South Med J 1993; 86(10): 1151–1153.
  • Lauterbach EC . Dextromethorphan as a potential rapid-acting antidepressant. Med Hypotheses 2011; 76(5): 717–719.
  • Frisher M, Crome I, Macleod J, et al. Predictive factors for illicit drug use among young people: a literature review. Home Office Online –1613.http://dera.ioe.ac.uk/6903/1/rdsolr0507.pdf..
Document Type
Publication order reference
Identifiers
YADDA identifier
bwmeta1.element.desklight-8ea8bbe1-f618-4f1c-b0cd-777f3e2fb35e
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.